CD4 and myeloid sarcoma: The percentage of CD8+ T cells was significantly decreased whereas the percentage of CD4+ T cells and the CD4:CD8 ratio were significantly increased in the total group of MS patients compared to healthy subjects; these changes were more pronounced in SPMS and PPMS than in RRMS.